September 10, 2015 | Aerie Pharmaceuticals and Ramot at the Tel Aviv University announced a research collaboration and licensing agreement for an age-related macular degeneration product. Aerie is a clinical stage pharmaceutical company developing therapies for the treatment of glaucoma and other eye diseases. Ramot is the technology transfer company of the Tel Aviv University.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments